Design Therapeutics, Inc. DSGN Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Design Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The official record: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Design Therapeutics, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Design Therapeutics, Inc.'s common stock?
- Design Therapeutics, Inc. (DSGN) reported common stock of $6K in Q1 2026.
- How has Design Therapeutics, Inc.'s common stock changed year-over-year?
- Design Therapeutics, Inc.'s common stock decreased by 0.0% year-over-year, from $6K to $6K.
- What is the long-term trend for Design Therapeutics, Inc.'s common stock?
- Over 5 years (2020 to 2025), Design Therapeutics, Inc.'s common stock has grown at a 43.1% compound annual growth rate (CAGR), from $1K to $6K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).